Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Ovarian cancer
Closed
Other
This study is looking at changes in ovarian cancer cells when women have a drug called GSK2110183. This study is for women who are taking part in a trial of GSK2110183 with chemotherapy for ovarian cancer.
Recruitment start: 10 December 2012
Recruitment end: 1 October 2014
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Sarah Blagden
Experimental Cancer Medicine Centre (ECMC)
Imperial College London
NIHR Clinical Research Network: Cancer
Ovarian Cancer Action
Last reviewed: 20 November 2014
CRUK internal database number: 10015